Accor Spadr New Stock Total Asset
| ACR1 Stock | EUR 9.50 0.05 0.53% |
ACCOR SPADR NEW fundamentals help investors to digest information that contributes to ACCOR SPADR's financial success or failures. It also enables traders to predict the movement of ACCOR Stock. The fundamental analysis module provides a way to measure ACCOR SPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ACCOR SPADR stock.
ACCOR |
ACCOR SPADR NEW Company Total Asset Analysis
ACCOR SPADR's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, ACCOR SPADR NEW has a Total Asset of 0.0. This is 100.0% lower than that of the Consumer Cyclical sector and 100.0% lower than that of the Lodging industry. The total asset for all Germany stocks is 100.0% higher than that of the company.
ACCOR Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ACCOR SPADR's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ACCOR SPADR could also be used in its relative valuation, which is a method of valuing ACCOR SPADR by comparing valuation metrics of similar companies.ACCOR SPADR is currently under evaluation in total asset category among its peers.
ACCOR Fundamentals
| Return On Equity | -0.0066 | |||
| Return On Asset | 0.0064 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.04 % | |||
| Shares Outstanding | 1.32 B | |||
| Price To Earning | 4.54 X | |||
| Revenue | 3.1 B | |||
| Gross Profit | 61 M | |||
| EBITDA | 219 M | |||
| Net Income | (46 M) | |||
| Cash And Equivalents | 2.83 B | |||
| Cash Per Share | 2.03 X | |||
| Total Debt | 4.03 B | |||
| Debt To Equity | 62.50 % | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | 3.05 X | |||
| Cash Flow From Operations | 491 M | |||
| Earnings Per Share | 0.04 X | |||
| Number Of Employees | 17.33 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 8.1 B | |||
| Z Score | 1.2 |
About ACCOR SPADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ACCOR SPADR NEW's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACCOR SPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACCOR SPADR NEW based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ACCOR Stock
ACCOR SPADR financial ratios help investors to determine whether ACCOR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACCOR with respect to the benefits of owning ACCOR SPADR security.